CODEXIS INC. - COMMON STOCK

Codexis Announces New Employment Inducement Grants

09 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Cowen 43rd Annual Health Care Conference

27 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results

23 Feb 2023 16:06:00 By Nasdaq GlobeNewswire

Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

23 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™

22 Feb 2023 16:05:21 By Nasdaq GlobeNewswire

Codexis Announces New Employment Inducement Grants

15 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23

09 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

23 Jan 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

20 Dec 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Provides Update on Prioritized Corporate Strategy

29 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

16 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

08 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2022 Financial Results

03 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

01 Nov 2022 08:00:03 By Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2022 Financial Results on November 3

20 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

03 Oct 2022 08:00:02 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

03 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

14 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2022 Financial Results

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

02 Aug 2022 16:05:01 By Nasdaq GlobeNewswire